SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hind Bio Science - Quaterly Results

29 Jul 2022 Evaluate
The sales surged to Rs. 2.71 millions, up 39.69% for the June 2022 quarter as against Rs. 1.94 millions during the corresponding quarter previous year.The Net Loss for the quarter ended June 2022 is Rs. -0.25 millions as compared to Net Loss of Rs. -0.76 millions of corresponding quarter ended June 2021 Operating profit Margin for the quarter ended June 2022 improved to -0.24% as compared to -0.74% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 2.71 1.94 39.69 2.71 1.94 39.69 4.36 10.32 -57.75
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.52 0.00 0.00
PBIDT -0.24 -0.74 -67.57 -0.24 -0.74 -67.57 -5.05 -9.39 -46.22
Interest 0.00 0.01 0.00 0.00 0.01 0.00 0.05 0.07 -28.57
PBDT -0.24 -0.75 -68.00 -0.24 -0.75 -68.00 -5.10 -9.46 -46.09
Depreciation 0.01 0.01 0.00 0.01 0.01 0.00 0.03 0.08 -62.50
PBT -0.25 -0.76 -67.11 -0.25 -0.76 -67.11 -5.13 -9.54 -46.23
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.03 -0.16 -118.75
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.01 200.00
PAT -0.25 -0.76 -67.11 -0.25 -0.76 -67.11 -5.16 -9.38 -44.99
Equity 102.51 102.51 0.00 102.51 102.51 0.00 102.51 102.51 0.00
PBIDTM(%) -8.86 -38.14 -76.78 -8.86 -38.14 -76.78 -115.83 -90.99 27.30

Hind Bio Science Share Price

9.24 0.44 (5.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×